- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Vascular Closure Devices Market Projected to Grow 5.70% Annually Through 2032
Key players include Abbott, Teleflex, and Medtronic as demand rises for minimally invasive cardiac procedures
Apr. 15, 2026 at 9:38pm
Got story updates? Submit your updates here. ›
Innovative vascular closure devices enable faster recovery and reduced complications for minimally invasive cardiac procedures.Las Vegas TodayThe global vascular closure devices market is forecast to expand from $1.55 billion in 2024 to $2.40 billion by 2032, growing at a CAGR of 5.70% during 2025-2032. This trajectory reflects increasing reliance on catheter-based cardiovascular interventions, rising global burden of heart disease, and sustained investment in innovative closure technologies.
Why it matters
Vascular closure devices play a critical role in minimally invasive cardiac procedures, enabling faster recovery times and reduced complications compared to traditional open surgery. As the global population ages and cardiovascular disease prevalence increases, demand for these devices is expected to rise steadily, particularly in North America and Europe where healthcare infrastructure and reimbursement policies support their adoption.
The details
Key drivers of the vascular closure devices market include the growing prevalence of cardiovascular diseases, rising preference for minimally invasive procedures, and rapid technological advancements. By product type, the active approximators category - led by suture-based solutions - dominates the market, while the femoral access site accounts for the largest share. Hospitals and clinics remain the leading end-user segment.
- The global vascular closure devices market is projected to grow from $1,548.87 million in 2024 to $2,398.52 million by 2032.
- This reflects a CAGR of 5.70% during the 2025-2032 forecast period.
The players
Abbott
A global medical device company that offers a range of vascular closure solutions.
Teleflex Incorporated
A medical technology company that provides vascular closure devices as part of its product portfolio.
Medtronic
A leading medical technology company that develops and manufactures vascular closure devices.
What’s next
As the vascular closure devices market continues to evolve, key areas to watch include the development of bioabsorbable materials, large-bore closure systems, next-generation suture-based approximators, and AI-powered innovations that enhance procedural precision and patient safety.
The takeaway
The steady growth projected for the vascular closure devices market underscores the increasing clinical reliance on minimally invasive cardiac procedures and the rising global burden of cardiovascular diseases. Leading medical technology companies are well-positioned to capitalize on these trends by investing in innovative closure solutions that improve patient outcomes and reduce healthcare costs.
Las Vegas top stories
Las Vegas events
Apr. 18, 2026
Voss Events: Drag BrunchApr. 18, 2026
BattleBots Filming: Pro League Tournament Session 1Apr. 18, 2026
WrestleMania Saturday




